Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Editorial Enquiries – GOLD
Editorial Enquiries – EMJ
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Editorial Enquiries – GOLD
Editorial Enquiries – EMJ
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Updates in
BRAF V600E
-Mutated mCRC
9
Mins
March 2024
The BRAF V600E mutation occurs in 8–12% of patients with metastatic colorectal cancer, and is associated with poor prognosis. This…
Read more
7
Mins
31st August 2017
Editor’s Pick: Renal Involvement in Multiple Myeloma
Multiple myeloma (MM) is a plasma cell disorder that represents almost 10% of haematologic malignancies.
8
Mins
31st August 2017
A Theoretical View of Ovarian Cancer Relapse
Ovarian cancer (OC) is a disease that almost invariably relapses even after optimal primary cytoreductive surgery and standard first-line platinum-based…
3
Mins
25th August 2017
Mesothelioma: A Dormant Threat
The industrialised world is truly a marvel; through years of innovation and invention, society has been rewarded with extreme technological advances.
3
Mins
9th August 2017
Spasmodic Dysphonia: What About It?
Spasmodic dysphonia (SD): what about it? That is the million-dollar question.
13th December 2016
Recent Developments in Regorafenib Treatment for Gastrointestinal Cancers: Presentations at the Meeting of the European Society for Medical Oncology (ESMO) Congress 2016
The European Society for Medical Oncology (ESMO) Congress was held in Copenhagen, Denmark from 7th–11th October 2016. The use of the promiscuous…
9
Mins
22nd November 2016
State-of-the-Art Integration of Multiple Kinase Inhibitors in the Treatment of Gastrointestinal Cancers
This symposium provided an overview of the efficacy and safety of multikinase inhibitors in colorectal cancer, including treatment sequencing, followed…
10
Mins
22nd November 2016
Optimising Salvage Therapy in Aggressive B Cell Non-Hodgkin Lymphoma
Prof D’Amore opened the symposium by highlighting that management of patients with relapsed or refractory aggressive B cell non-Hodgkin lymphoma…
2
Mins
22nd November 2016
Cabozantinib as First-Line Therapy for Patients with Metastatic Renal Cell Carcinoma with Poor or Intermediate-Risk Characteristics
The oral vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor (TKI) sunitinib is a standard first-line therapy for patients with…
Loading posts...
« Previous
1
…
16
17
18
19
20
…
26
Next »